enGene Therapeutics Inc. (ENGN): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0001231919-26-000931

Filer

enGene Therapeutics Inc. (CIK 1980845)